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j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrPrefacePreface to special issue on nanoscale membrane organisationsThe plasma membrane limits, protects and deﬁnes cell identity,
separating two aqueous compartments: the cytoplasm from the extra-
cellular space. However, cells need to transport nutrients, ions and
waste products across their plasma membrane and also need to
communicate with other cells. Cells intercommunicate usingmembrane
receptors which transmit signals to the cytoplasm upon binding to their
extracellular ligands. The extracellular ligands are soluble molecules or
proteins embedded in the plasma membrane of other cells. In this way,
the plasmamembrane has a double function: (i) as a barrier, constituted
by a lipid bilayer, and (ii) as a communication platform, provided by
protein receptors anchored to the lipid bilayer. The distribution and
organisation of membrane receptors within the membrane is not
irrelevant to their function, since receptors not only transmit outside–
in information, a process coined as signal transduction, in the plane per-
pendicular to the plasma membrane, but can also inﬂuence each other
in a horizontal manner, a process that can lead to cooperativity
phenomena.
A ﬁrst model of plasma membrane organisation was proposed in
1972 by Singer and Nicolson who proposed that transmembrane
proteins and lipids are homogeneously distributed and freely diffusing.
This is known as the ﬂuid mosaic model [1]. The validity of the ﬂuid
mosaic model was already challenged in the 1970s by Stier and
Sackmannwhoproposed that the different chemico-physical properties
of the lipids in the plasmamembranewouldmake them to self-organise
in microdomains thus breaking the homogenous landscape of the ﬂuid
mosaic model [2]. The most prominent lipid microdomains are formed
by cholesterol and sphingolipids, which self-associate forming a liquid-
ordered phase (lipid raft), and separate from common phospholipids,
which form a lipid-disordered phase. Consequent with this heteroge-
neous distribution of lipids Simons and Ikonen proposed thatmembrane
proteins would also distribute non-homogenously and would have to
partition either to the raft or to the non-raft phases [3]. The idea that
membrane proteins are non-randomly distributed in membranes was
supported by immuno-gold labelling electron microscopy studies on
the distribution of receptors for immunoglobulins in mast cells [4].
However, the study of the distribution of antigen receptors in B and T
lymphocytes [5,6] led to the idea that membrane proteins of the same
type tend to concentrate in small areas of the membrane, forming
oligomers of different size before the receptors are exposed to their
extracellular ligands. Many receptors are now known to form
nanometre-sized oligomers known as nanoclusters before ligand binding
[5–9]. The distribution of membrane receptors in self-assembled
nanoclusters is consequent with the general distribution of membrane
proteins detected by electronmicroscopy and that led to the formulation
of the protein island model in distinction, but not in contrast to, the lipid
raft model [10]. Protein islands containing speciﬁc receptor nanoclustershttp://dx.doi.org/10.1016/j.bbamcr.2015.02.003
0167-4889/© 2015 Elsevier B.V. All rights reserved.seem to be organised by the residentmembrane proteins themselves, the
different membrane lipids and the underlying cytoskeleton [11].
In this special issue of BBA — Molecular Cell Research entitled
“Nanoscale Membrane Organisation and Signalling” we discuss new
developments in our understanding of how membrane proteins and
lipids are organised in biomembranes, with a focus on the plasma
membrane and proteins involved in signalling. The idea for this special
issue originates to an international symposium on “NanoscaleMembrane
Organisation” that was organised by the excellence cluster BIOSS of the
University of Freiburg from the 24th to 25th October 2013; http://www.
bioss.uni-freiburg.de/cms/3055.html.
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